Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel
- DOI
- 10.1186/s12885-020-07426-8
- Published
- 2020-10-02
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-020-07426-8,
title = {Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel},
author = {Hakon Blomstrand and Henrik Green and Mats Fredrikson and Emma Gränsmark and Bergthor Björnsson and Nils O. Elander},
year = {2020},
journal = {BMC Cancer},
doi = {10.1186/s12885-020-07426-8},
url = {https://doi.org/10.1186/s12885-020-07426-8}
}RIS
TY - JOUR TI - Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel AU - Hakon Blomstrand AU - Henrik Green AU - Mats Fredrikson AU - Emma Gränsmark AU - Bergthor Björnsson AU - Nils O. Elander PY - 2020 JO - BMC Cancer DO - 10.1186/s12885-020-07426-8 UR - https://doi.org/10.1186/s12885-020-07426-8 ER -
APA
Blomstrand, H., Green, H., Fredrikson, M., Gränsmark, E., Björnsson, B., & Elander, N. O. (2020). Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel. BMC Cancer. https://doi.org/10.1186/s12885-020-07426-8
Source records
- crossref · retrieved 2026-09-27T01:36:15.565Z